glp-1 news today cardiovascular outcomes 2025 november trends 2025: real-world data, patient & future therapies ISPOR 2025: Exploring reasons for

If you have struggled with obesity for a long time, it is not recommended that you stop taking GLP-1 medication

The combinations angiogenic effects are especially relevant here, since adequate blood supply is critical for bone repair

Cook in 1 teaspoon olive oil

3 The obesity drug market is evolving into a multi-format platform race

Compared with semaglutide users in a randomized controlled trial (STEP 10) who lost a similar share of weight while on medication, Noom GLP-1Rx members particularly those with high habit persistence showed better weight maintenance six months after stopping

PMID: 39996356 | DOI Murphy C, Koehler K